American Oncology Network (AONC)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	19.43 mm	19.43 mm	19.43 mm	19.43 mm	19.43 mm	19.43 mm
Cash burn (monthly)	4.80 mm	2.69 mm	(no burn)	3.85 mm	9.36 mm	2.40 mm
Cash used (since last report)	24.38 mm	13.65 mm	n/a	19.60 mm	47.58 mm	12.21 mm
Cash remaining	-4.94 mm	5.78 mm	n/a	-163.99 k	-28.15 mm	7.22 mm
Runway (months of cash)	-1.0	2.2	n/a	-0.0	-3.0	3.0

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2024

AONC institutional ownership history Ownership history

51.4% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	3	4	-25.0%
Opened positions	0	0
Closed positions	1	33	-97.0%
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	15.80 mm	22.02 mm	-28.2%
Total shares	13.93 mm	14.14 mm	-1.5%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Digital Transformation Sponsor	11.39 mm	$0.00	0.0%
HealthQuest Tactical Opportunities Fund	2.05 mm	$12.26 mm	0.0%
Aea Growth Equity Fund	501.70 k	$3.54 mm	0.0%

Largest transactions	Shares	Bought/sold	Change
Security Benefit Life Insurance	0.00	-207.31 k	EXIT
Digital Transformation Sponsor	11.39 mm	0.00	0.0%
Aea Growth Equity Fund	501.70 k	0.00	0.0%
HealthQuest Tactical Opportunities Fund	2.05 mm	0.00	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

AONC insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	#Shares	#Remaining
16 Jul 24	Stephen Divers	Class A Common Stock	Grant	Acquire A	No	No	36,000	98,470
16 Jul 24	David Afshar	Class A Common Stock	Grant	Acquire A	No	No	150,000	150,000
16 Jul 24	Erica Mallon	Class A Common Stock	Grant	Acquire A	No	No	36,000	36,000
16 Jul 24	Fluegel Bradley M	Class A Common Stock	Grant	Acquire A	No	No	5,000	44,981
16 Jul 24	Todd Schonherz	Class A Common Stock	Grant	Acquire A	No	No	300,000	305,340

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Press releases

From Benzinga Pro

Hematology Oncology of Indiana Physician Research Presented at 66th ASH Annual Meeting

30 Dec 24

INDIANAPOLIS, IN., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Board-certified medical oncologists, M. Sarfraz Nawaz, MD and Ruemu E. Birhiray, MD from community oncology practice Hematology Oncology of Indiana (HOI), a partner

American Oncology Network's Specialty Pharmacy Achieves ACHC Reaccreditation

19 Dec 24

FORT MYERS, FL, Dec. 19, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (OTCQX:AONC), one of the fastest-growing oncology networks in the United States, proudly announces that its specialty pharmacy has